Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosisResearch article Published on 2022-03-012022-10-05 Journal: Clinics in dermatology [Category] COVID19(2023년), SARS, 변종, [키워드] Activation complement courses COVID-19 COVID-19 infection Cutaneous death described disease dominant Endotheliitis heterogeneous manifestation Mild Necrosis pandemic pathophysiologic patients with COVID-19 perivascular inflammation polymerase chain reported SARS-CoV-2 survived tissue tissue damage Trigger Vasculitis while [DOI] 10.1016/j.clindermatol.2022.02.013 [Article Type] Research article
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant SurgeDelta Variant Surge 전후에 미국에서 COVID-19 감염 및 입원을 예방하기 위한 단일 용량 Ad26.COV2.S 백신의 내구성Article Published on 2022-03-012022-09-11 Journal: JAMA Network Open [Category] SARS, 변종, [키워드] 95% CI Ad26 Ad26.COV2.S Ad26.COV2.S vaccine age association Clinical practice clinical trial cohort study collected Comorbidity COVID-19 COVID-19 infection COVID-19 infections COVID-19 vaccine Critical Delta delta variant demonstrated dominant Effectiveness Efficacy estimate Factors followed by Hospitalization hospitalizations Immunocompromised patient Immunocompromised patients incidence individual Infection location Older outcome pandemic prevention propensity score matching randomized clinical trials receiving recorded Risk factors SARS-CoV-2 virus Sex subgroup subgroups the SARS-CoV-2 virus vaccinated individual vaccinated individuals vaccination Vaccinations variant variants women [DOI] 10.1001/jamanetworkopen.2022.2959 PMC 바로가기 [Article Type] Article
Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA2개의 동시 순환 SARS-CoV-2 변이체의 시공간 분석, 미국 뉴욕주Research Published on 2022-03-012022-09-10 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, [키워드] (alpha acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 alarm analyses B.1.1.7 B.1.526 coronavirus coronavirus disease COVID-19 dominant dominant lineage help immune evasion infections initial Iota methodology New York New York City pandemic raised Region respiratory respiratory infections SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severe acute respiratory syndrome coronavirus 2 shifting spatiotemporal spatiotemporal analyses Spread state trajectory Transmissibility United States USA vaccine-preventable diseases variant viruses zoonoses [DOI] 10.3201/eid2803.211972 PMC 바로가기 [Article Type] Research
A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY이탈리아 북부 롬바르디아주 F490S에 추가로 우려되는 SARS-COV-2 델타 변종 클러스터Article Published on 2022-03-012022-09-11 Journal: International Journal of Infectious Diseases [Category] SARS, 변종, [키워드] appear B.1.617.2 caused Cluster COVID-19 Delta delta variant dominant Efficacy F490S immune escape mutation impair Lambda Mutation Prevalence SARS-CoV-2 subject Vaccine vaccine efficacy variant variant of concern VoC were infected [DOI] 10.1016/j.ijid.2021.12.362 PMC 바로가기 [Article Type] Article
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination동종 및 이종 CoronaVac 또는 BNT162b2 백신 접종 후 SARS-CoV-2 Omicron 변이체 BA.1에 대한 중화 항체Article Published on 2022-03-012022-09-11 Journal: Nature Medicine [Category] SARS, 변종, 진단, [키워드] antibody Antibody titer BNT162b2 booster booster dose circulating convalescent CoronaVac country dominant dose Effectiveness elicited geometric mean geometric mean titer GMT Heterologous homologous individual infected individual Infection Live virus Messenger RNA Neutralizing activity of BNT162b2 omicron Omicron variant plaque plaque reduction neutralization PRNT reduced reductions reductions in SARS-CoV-2 SARS-CoV-2 virus serum serum antibody Spread the SARS-CoV-2 threshold to define vaccinated individual vaccinated individuals vaccination Vaccine variant virus wild-type WT virus [DOI] 10.1038/s41591-022-01704-7 PMC 바로가기 [Article Type] Article
Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021스파이크 유전자 표적 실패 데이터를 사용하여 SARS-CoV-2 Omicron 변이의 출현에 대한 역학 감시 강화, 2021년 11월 15일부터 12월 31일까지 영국Article Published on 2022-03-012022-09-11 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] applied COVD-19 delta variant differentiation disease Disease surveillance dominant England Enhancing epidemiological growth management omicron public health S gene S gene target failure s-gene target failure. sample collection SARS-CoV-2 spike gene Surveillance the SARS-CoV-2 variant [DOI] 10.2807/1560-7917.ES.2022.27.11.2200143 PMC 바로가기 [Article Type] Article
Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, EnglandArticles Published on 2022-02-262022-10-31 Journal: EClinicalMedicine [Category] COVID-19, [키워드] Alpha antibody Antibody testing Blood circulating Community confirmed case COVID-19 Delta variants Department dominant Education setting emergence England English enrolled finding funding Infection infection rate initiated investigated lockdown nasal swab National participant PCR PCR testing PCR-positive Prospective remained risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleoprotein SARS-CoV-2 RT-PCR School Schools security Seroconversion seroconversion rate Spike protein Surveillance surveillance data teenagers Transmission trend vaccination variant [DOI] 10.1016/j.eclinm.2022.101319 PMC 바로가기 [Article Type] Articles
Delta Variant with P681R Critical Mutation Revealed by Ultra-Large Atomic-Scale Ab Initio Simulation: Implications for the Fundamentals of Biomolecular Interactions초대형 원자 규모 Ab 초기 시뮬레이션으로 밝혀진 P681R 치명적 돌연변이가 있는 델타 변이체: 생체 분자 상호 작용의 기본 사항에 대한 의미Article Published on 2022-02-242022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, [키워드] Affect Amino acid amino acids amino-acid–amino-acid bond pair atomic resolution computational modeling D614G D614G mutation damage Delta delta variant domain dominant Efficiency explain faster flexibility furin furin cleavage site human cell human cells infection rate interacting residue interacting residues Interaction interactions interatomic interaction machine learning Mutation mutations offer P681R protocol reduce reduced reported responsible Revealed SARS-CoV-2 Spike protein spike-protein Spread the spike protein unique virus wild type [DOI] 10.3390/v14030465 PMC 바로가기 [Article Type] Article
Analyses of Long-Term Epidemic Trends and Evolution Characteristics of Haplotype Subtypes Reveal the Dynamic Selection on SARS-CoV-2일배체형 하위유형의 장기 전염병 경향 및 진화 특성 분석은 SARS-CoV-2에 대한 동적 선택을 보여줍니다Article Published on 2022-02-232022-09-11 Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] analyzed B.1 B.1.1 change Characteristics country death dominant dramatic increase dynamic Epidemic epidemic trends Evolution genome sequence greater H1-5 Haplotype haplotype subtypes help highest Immune escape Ka/K Ka/Ks missing molecular Non-synonymous North America Outbreaks pandemic Positive selection Prevalence Region respond SARS-CoV-2 SARS-CoV-2 genomic data SARS-COV-2 infection Selection substitution rate. subtype synonymous the epidemic the United State Transmissibility trend United States [DOI] 10.3390/v14030454 PMC 바로가기 [Article Type] Article
Population Immunity and Covid-19 Severity with Omicron Variant in South AfricaOriginal Article Published on 2022-02-232022-10-04 Journal: The New England Journal of Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료법, [키워드] 95% CI 95% confidence interval acute respiratory syndrome age B.1.1.529 changes in children circulating conducted coronavirus coronavirus disease death deaths declined determine dominant evaluated Hospitalization hospitalizations household IgG incidence increase in Infection Melinda Gate nucleocapsid protein Older omicron Omicron variant pandemic participant Participants Population proportion Quantitative assays ranged recorded Result Sample SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 spike protein seropositive South Africa tested Vaccine variant [DOI] 10.1056/NEJMoa2119658 PMC 바로가기 [Article Type] Original Article